News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,940 Results
Type
Article (14120)
Company Profile (282)
Press Release (250538)
Section
Business (79464)
Career Advice (152)
Deals (13221)
Drug Delivery (35)
Drug Development (50408)
Employer Resources (31)
FDA (5705)
Job Trends (5125)
News (144308)
Policy (10025)
Tag
Academia (906)
Alliances (21613)
Alzheimer's disease (800)
Antibody-drug conjugate (ADC) (78)
Approvals (5710)
Artificial intelligence (98)
Bankruptcy (102)
Best Places to Work (4560)
Biotechnology (232)
Breast cancer (132)
Cancer (1145)
Cardiovascular disease (92)
Career advice (132)
CAR-T (98)
Cell therapy (285)
Clinical research (40611)
Collaboration (453)
Compensation (186)
COVID-19 (1028)
C-suite (122)
Cystic fibrosis (75)
Data (1181)
Diabetes (108)
Diagnostics (1282)
Earnings (29312)
Events (47791)
Executive appointments (368)
FDA (6229)
Funding (422)
Gene editing (79)
Gene therapy (207)
GLP-1 (340)
Government (1072)
Healthcare (6579)
Infectious disease (1081)
Inflammatory bowel disease (106)
IPO (7249)
Job creations (859)
Job search strategy (127)
Layoffs (197)
Legal (1384)
Lung cancer (164)
Manufacturing (105)
Medical device (2580)
Medtech (2581)
Mergers & acquisitions (6210)
Metabolic disorders (324)
Neuroscience (1125)
NextGen: Class of 2025 (2012)
Non-profit (852)
Northern California (1376)
Obesity (168)
Opinion (98)
Parkinson's disease (90)
Patents (92)
People (25387)
Phase I (14336)
Phase II (18895)
Phase III (11936)
Pipeline (548)
Postmarket research (852)
Preclinical (6006)
Radiopharmaceuticals (210)
Rare diseases (253)
Real estate (1414)
Regulatory (8462)
Research institute (935)
Series A (82)
Southern California (1231)
Startups (1969)
United States (10900)
Vaccines (192)
Weight loss (96)
Date
Last 7 days (471)
Last 30 days (1509)
Last 365 days (20319)
2025 (3116)
2024 (20554)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Asia (17121)
Australia (2896)
California (3148)
Canada (980)
China (281)
Colorado (119)
Connecticut (132)
Delaware (76)
Europe (36820)
Florida (366)
Georgia (93)
Illinois (195)
Indiana (76)
Maryland (409)
Massachusetts (2498)
Minnesota (123)
New Jersey (785)
New York (870)
North Carolina (485)
Northern California (1376)
Ohio (99)
Pennsylvania (593)
South America (207)
Southern California (1231)
Texas (350)
Washington State (296)
264,940 Results for "coya therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Coya Therapeutics Announces Pipeline Expansion - COYA 303: COYA 301 in Combination with GLP-1 Receptor Agonist for the Treatment of Inflammatory Diseases
January 21, 2025
·
7 min read
Press Releases
Coya Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
6 min read
Press Releases
Coya Therapeutics to Participate in KOL Call Hosted by BTIG to Discuss the Potential Treatment of Alzheimer’s Disease Using GLP-1 Agonists and Combinations
February 26, 2025
·
6 min read
Lone Star Bio
Coya Therapeutics Issues Letter to Stockholders Highlighting Expansion of COYA 302 into Alzheimer’s Disease and Coya’s Pathway to a “Pipeline in a Product”
Coya Therapeutics Issues Letter to Stockholders Highlighting Expansion of COYA 302 into Alzheimer’s Disease and Coya’s Pathway to a “Pipeline in a Product”.
February 21, 2024
·
19 min read
Lone Star Bio
Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology
Coya Therapeutics, Inc. announces the acceptance of a peer-reviewed manuscript.
June 3, 2024
·
10 min read
Business
Coya Therapeutics Expands Sponsored Research Collaboration with Houston Methodist Research Institute
Coya Therapeutics, Inc. announces the expansion of its research collaboration with the Houston Methodist Research Institute (“HMRI”) through a sponsored research agreement (SRA) covering multiple initiatives.
June 20, 2024
·
10 min read
Press Releases
Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders
November 20, 2024
·
11 min read
Business
Coya Therapeutics Announces Inclusion in the MSCI USA Micro Cap Index
Coya Therapeutics, Inc. announces that MSCI has selected the Company’s shares for inclusion in its MSCI USA Micro Cap Index at the market close of May 31, 2024.
May 28, 2024
·
6 min read
Business
Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results
Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a corporate update and announces its financial results for the quarter ended March 31, 2024.
May 9, 2024
·
13 min read
Press Releases
Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference
November 25, 2024
·
6 min read
1 of 26,494
Next
